更新日期 | 產(chǎn)品編號(hào) | 品牌 | 產(chǎn)品信息 | CAS號(hào) | MDL號(hào) | 規(guī)格與純度 | 包裝 | 價(jià)格 | 庫(kù)存信息 | 操作 |
2024/11/08
|
XW0251905454704
|
|
4-甲基-7-(4,4,5,5-四甲基-1,3,2-二氧雜硼雜環(huán)戊烷-2-基)-3,4-二氫-2H-苯并[b][1,4]噁嗪 4-Methyl-7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,4-dihydro-2H-benzo[b][1,4]oxazine
|
|
|
|
5g
|
5020元
|
請(qǐng)?jiān)冐浧?
|
詳細(xì)
|
2024/11/08
|
XW0251905454703
|
|
4-甲基-7-(4,4,5,5-四甲基-1,3,2-二氧雜硼雜環(huán)戊烷-2-基)-3,4-二氫-2H-苯并[b][1,4]噁嗪 4-Methyl-7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,4-dihydro-2H-benzo[b][1,4]oxazine
|
|
|
|
1g
|
1004元
|
請(qǐng)?jiān)冐浧?
|
詳細(xì)
|
2024/11/08
|
XW0251905454702
|
|
4-甲基-7-(4,4,5,5-四甲基-1,3,2-二氧雜硼雜環(huán)戊烷-2-基)-3,4-二氫-2H-苯并[b][1,4]噁嗪 4-Methyl-7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,4-dihydro-2H-benzo[b][1,4]oxazine
|
|
|
|
250mg
|
553元
|
請(qǐng)?jiān)冐浧?
|
詳細(xì)
|
2024/11/08
|
XW0251905454701
|
|
4-甲基-7-(4,4,5,5-四甲基-1,3,2-二氧雜硼雜環(huán)戊烷-2-基)-3,4-二氫-2H-苯并[b][1,4]噁嗪 4-Methyl-7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,4-dihydro-2H-benzo[b][1,4]oxazine
|
|
|
|
100mg
|
364元
|
請(qǐng)?jiān)冐浧?
|
詳細(xì)
|
2017/11/01
|
CC13539CB
|
|
4-甲基-7-(4,4,5,5-四甲基-1,3,2-二氧硼烷-2-基)-3,4-二氫-2H-1,4-苯并惡嗪 4-methyl-7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,4-dihydro-2H-1,4-benzoxazine
|
519054-54-7
|
|
|
250MG
|
1545元
|
|
詳細(xì)
|
2017/11/01
|
CC13539DA
|
|
4-甲基-7-(4,4,5,5-四甲基-1,3,2-二氧硼烷-2-基)-3,4-二氫-2H-1,4-苯并惡嗪 4-methyl-7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,4-dihydro-2H-1,4-benzoxazine
|
519054-54-7
|
|
|
1GR
|
4769元
|
|
詳細(xì)
|
2017/11/01
|
CC13539DE
|
|
4-甲基-7-(4,4,5,5-四甲基-1,3,2-二氧硼烷-2-基)-3,4-二氫-2H-1,4-苯并惡嗪 4-methyl-7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,4-dihydro-2H-1,4-benzoxazine
|
519054-54-7
|
|
|
5GR
|
13579元
|
|
詳細(xì)
|